Global Human Microbiome Sequencing Technology Market Growth (Status and Outlook) 2020-2025

Global Human Microbiome Sequencing Technology Market Growth (Status and Outlook) 2020-2025

COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.

According to this latest study, the 2020 growth of Human Microbiome Sequencing Technology will have significant change from previous year. By the most conservative estimates of global Human Microbiome Sequencing Technology market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Human Microbiome Sequencing Technology market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Microbiome Sequencing Technology market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Human Microbiome Sequencing Technology, covering the supply chain analysis, impact assessment to the Human Microbiome Sequencing Technology market size growth rate in several scenarios, and the measures to be undertaken by Human Microbiome Sequencing Technology companies in response to the COVID-19 epidemic.

Segmentation by technology: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Traditional Sequencing Technologies
Next-Generation Sequencing
Third Generation Sequencing

Segmentation by end users: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Research and Academic Institutions
Pharmaceutical and Biotechnology Companies
Hospital and Clinic
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Baseclear B.V.
Oxford Nanopore Technologies, Inc.
Beijing Genomics Institute (BGI) Genomics Co., Ltd
Clinical Microbiomics A/S
Eurofins Scientific SE
Charles River Laboratories International Inc.
Novogene Corporation
GENEWIZ, Inc.
OraSure Technologies, Inc.
Illumina, Inc.
CosmosID
Microba
Leucine Rich Bio Pvt. Ltd.
Pacific Biosciences of California, Inc.
Thermo Fisher Scientific Inc.
Second Genome, Inc.
Molzym GmbH & Co. KG
Viome, Inc.
QIAGEN N.V.
Microbiome Insights Inc.

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Human Microbiome Sequencing Technology market size by key regions/countries, technology and end users, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Human Microbiome Sequencing Technology market by identifying its various subsegments.
Focuses on the key global Human Microbiome Sequencing Technology players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Human Microbiome Sequencing Technology with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Human Microbiome Sequencing Technology submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

Please note: The report will take approximately 2 business days to prepare and deliver.


1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
1.7 What is the Impact of Covid-19 Outbreak On the Human Microbiome Sequencing Technology?
1.7.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.7.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.7.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Human Microbiome Sequencing Technology Market Size in 2020, by Scenario
1.7.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Human Microbiome Sequencing Technology Market Size 2015-2025
2.1.2 Human Microbiome Sequencing Technology Market Size CAGR by Region
2.2 Human Microbiome Sequencing Technology Segment by Technology
2.2.1 Traditional Sequencing Technologies
2.2.2 Traditional Sequencing Technologies
2.2.3 Third Generation Sequencing
2.3 Human Microbiome Sequencing Technology Market Size by Technology
2.3.1 Global Human Microbiome Sequencing Technology Market Size Market Share by Technology (2015-2020)
2.3.2 Global Human Microbiome Sequencing Technology Market Size Growth Rate by Technology (2015-2020)
2.4 Human Microbiome Sequencing Technology Segment by End Users
2.4.1 Research and Academic Institutions
2.4.2 Pharmaceutical and Biotechnology Companies
2.4.3 Hospital and Clinic
2.4.4 Others
2.5 Human Microbiome Sequencing Technology Market Size by End Users
2.5.1 Global Human Microbiome Sequencing Technology Market Size Market Share by End Users (2015-2020)
2.5.2 Global Human Microbiome Sequencing Technology Market Size Growth Rate by End Users (2015-2020)
3 Global Human Microbiome Sequencing Technology by Players
3.1 Global Human Microbiome Sequencing Technology Market Size Market Share by Players
3.1.1 Global Human Microbiome Sequencing Technology Market Size by Players (2018-2020)
3.1.2 Global Human Microbiome Sequencing Technology Market Size Market Share by Players (2018-2020)
3.2 Global Human Microbiome Sequencing Technology Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Human Microbiome Sequencing Technology by Regions
4.1 Human Microbiome Sequencing Technology Market Size by Regions
4.2 Americas Human Microbiome Sequencing Technology Market Size Growth
4.3 APAC Human Microbiome Sequencing Technology Market Size Growth
4.4 Europe Human Microbiome Sequencing Technology Market Size Growth
4.5 Middle East & Africa Human Microbiome Sequencing Technology Market Size Growth
5 Americas
5.1 Americas Human Microbiome Sequencing Technology Market Size by Countries
5.2 Americas Human Microbiome Sequencing Technology Market Size by Technology
5.3 Americas Human Microbiome Sequencing Technology Market Size by End Users
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Human Microbiome Sequencing Technology Market Size by Regions
6.2 APAC Human Microbiome Sequencing Technology Market Size by Technology
6.3 APAC Human Microbiome Sequencing Technology Market Size by End Users
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Human Microbiome Sequencing Technology by Countries
7.2 Europe Human Microbiome Sequencing Technology Market Size by Technology
7.3 Europe Human Microbiome Sequencing Technology Market Size by End Users
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Human Microbiome Sequencing Technology by Countries
8.2 Middle East & Africa Human Microbiome Sequencing Technology Market Size by Technology
8.3 Middle East & Africa Human Microbiome Sequencing Technology Market Size by End Users
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Human Microbiome Sequencing Technology Market Forecast
10.1 Global Human Microbiome Sequencing Technology Market Size Forecast (2021-2025)
10.2 Global Human Microbiome Sequencing Technology Forecast by Regions
10.2.1 Global Human Microbiome Sequencing Technology Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Human Microbiome Sequencing Technology Forecast by Technology
10.8 Global Human Microbiome Sequencing Technology Forecast by End Users
11 Key Players Analysis
11.1 Baseclear B.V.
11.1.1 Company Details
11.1.2 Human Microbiome Sequencing Technology Product Offered
11.1.3 Baseclear B.V. Human Microbiome Sequencing Technology Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Baseclear B.V. News
11.2 Oxford Nanopore Technologies, Inc.
11.2.1 Company Details
11.2.2 Human Microbiome Sequencing Technology Product Offered
11.2.3 Oxford Nanopore Technologies, Inc. Human Microbiome Sequencing Technology Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Oxford Nanopore Technologies, Inc. News
11.3 Beijing Genomics Institute (BGI) Genomics Co., Ltd
11.3.1 Company Details
11.3.2 Human Microbiome Sequencing Technology Product Offered
11.3.3 Beijing Genomics Institute (BGI) Genomics Co., Ltd Human Microbiome Sequencing Technology Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Beijing Genomics Institute (BGI) Genomics Co., Ltd News
11.4 Clinical Microbiomics A/S
11.4.1 Company Details
11.4.2 Human Microbiome Sequencing Technology Product Offered
11.4.3 Clinical Microbiomics A/S Human Microbiome Sequencing Technology Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Clinical Microbiomics A/S News
11.5 Eurofins Scientific SE
11.5.1 Company Details
11.5.2 Human Microbiome Sequencing Technology Product Offered
11.5.3 Eurofins Scientific SE Human Microbiome Sequencing Technology Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Eurofins Scientific SE News
11.6 Charles River Laboratories International Inc.
11.6.1 Company Details
11.6.2 Human Microbiome Sequencing Technology Product Offered
11.6.3 Charles River Laboratories International Inc. Human Microbiome Sequencing Technology Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Charles River Laboratories International Inc. News
11.7 Novogene Corporation
11.7.1 Company Details
11.7.2 Human Microbiome Sequencing Technology Product Offered
11.7.3 Novogene Corporation Human Microbiome Sequencing Technology Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Novogene Corporation News
11.8 GENEWIZ, Inc.
11.8.1 Company Details
11.8.2 Human Microbiome Sequencing Technology Product Offered
11.8.3 GENEWIZ, Inc. Human Microbiome Sequencing Technology Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 GENEWIZ, Inc. News
11.9 OraSure Technologies, Inc.
11.9.1 Company Details
11.9.2 Human Microbiome Sequencing Technology Product Offered
11.9.3 OraSure Technologies, Inc. Human Microbiome Sequencing Technology Revenue, Gross Margin and Market Share (2018-2020)
11.9.4 Main Business Overview
11.9.5 OraSure Technologies, Inc. News
11.10 Illumina, Inc.
11.10.1 Company Details
11.10.2 Human Microbiome Sequencing Technology Product Offered
11.10.3 Illumina, Inc. Human Microbiome Sequencing Technology Revenue, Gross Margin and Market Share (2018-2020)
11.10.4 Main Business Overview
11.10.5 Illumina, Inc. News
11.11 CosmosID
11.12 Microba
11.13 Leucine Rich Bio Pvt. Ltd.
11.14 Pacific Biosciences of California, Inc.
11.15 Thermo Fisher Scientific Inc.
11.16 Second Genome, Inc.
11.17 Molzym GmbH & Co. KG
11.18 Viome, Inc.
11.19 QIAGEN N.V.
11.20 Microbiome Insights Inc.
12 Research Findings and Conclusion

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook